Complete Two-Year Follow-Up With Formal Non-Inferiority Testing on Primary Outcomes of the AIDA Trial Comparing the Absorb Bioresorbable Scaffold With the XIENCE Drug-Eluting Metallic Stent in Routine PCI

EuroIntervention - France
doi 10.4244/eij-d-18-00335
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Europa Digital & Publishing

Related search

Safety and Efficacy of Policosanol in Patients With High On-Treatment Platelet Reactivity After Drug-Eluting Stent Implantation: Two-Year Follow-Up Results

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE v Stent in a Porcine Coronary Artery Model

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2014English

Long-Term Clinical Outcomes of Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients With Coronary Artery Disease (LEADERS): 4 Year Follow-Up of a Randomised Non-Inferiority Trial

The Lancet
Medicine
2011English

Clinical Outcomes of Bioabsorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Two-Year Follow-Up of the DESSOLVE III Trial

EuroIntervention
MedicineCardiovascular MedicineCardiology
2020English

Sealing of Calcified Plaques After Bioresorbable Scaffold Implantations: A Five-Year Follow Up

International Journal of Cardiovascular Imaging
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2016English

Absorb GT1 Bioresorbable Vascular Scaffold System ― 1-Year Post-Marketing Surveillance in Japan ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Seven-Year Clinical Outcomes of Unprotected Left Main Coronary Artery Stenting With Drug-Eluting Stent and Bare-Metal Stent

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Initial Experience With Everolimus-Eluting Bioresorbable Vascular Scaffolds for Treatment of Patients Presenting With Acute Myocardial Infarction: A Propensity-Matched Comparison to Metallic Drug Eluting Stents 18-Month Follow-Up of the BVS STEMI First Study

EuroIntervention
MedicineCardiovascular MedicineCardiology
2016English

Patient Profile and Periprocedural Outcomes of Bioresorbable Vascular Scaffold Implantation in Comparison With Drug-Eluting and Bare-Metal Stent Implantation. Experience From ORPKI Polish National Registry 2014–2015

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy